Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 620319, 9 pages
http://dx.doi.org/10.1093/ecam/nep225
Original Article

Attenuated Combined Action of Cyclosporine A and Hyperlipidemia on Atherogenesis in Rabbits by Thymoquinone

1Department of Medicine, Royal University Hospital, University of Saskatchewan, Saskatoon, SK, Canada
2School of Pharmacy, Pacific University, Hillsboro, OR, USA
3Department of Physiology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada

Received 11 June 2009; Accepted 1 December 2009

Copyright © 2011 Ahmed Ragheb et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. L. Kasiske, “Epidemiology of cardiovascular disease after renal transplantation,” Transplantation, vol. 72, no. 6, pp. S5–S8, 2001. View at Google Scholar · View at Scopus
  2. L. C. Paul, “Chronic allograft nephropathy: an update,” Kidney International, vol. 56, no. 3, pp. 783–793, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Jonasson, J. Holm, and G. K. Hansson, “Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 7, pp. 2303–2306, 1988. View at Publisher · View at Google Scholar · View at Scopus
  4. S. E. Roselaar, G. Schonfeld, and A. Daugherty, “Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity,” Journal of Clinical Investigation, vol. 96, no. 3, pp. 1389–1394, 1995. View at Google Scholar · View at Scopus
  5. J. Galle, P. Schollmeyer, and C. Wanner, “Cyclosporin and oxidized low density lipoproteins synergistically potentiate vasoconstriction: influence of the endothelium,” European Heart Journal, vol. 14, no. I, pp. 111–117, 1993. View at Google Scholar · View at Scopus
  6. A. F. Drew and P. G. Tipping, “Cyclosporine treatment reduces early atherosclerosis in the cholesterol-fed rabbit,” Atherosclerosis, vol. 116, no. 2, pp. 181–189, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. R. H. Bourgain, H. Vermariën, R. Andries et al., “A standardized 'in vivo' model for the study of experimental arterial thrombosis: description of a method,” Advances in Experimental Medicine and Biology, vol. 180, pp. 635–649, 1984. View at Google Scholar · View at Scopus
  8. A. M. Gown, “Cell type and cell state specific antibodies in the analysis of early lesions of human atherosclerosis,” American Journal of Hypertension, vol. 5, no. 6, pp. S114–S117, 1992. View at Google Scholar · View at Scopus
  9. K. Prasad and J. Kalra, “Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E,” American Heart Journal, vol. 125, no. 4, pp. 958–973, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Steinberg, “Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop (September 5-6, 1991, Bethesda, MD),” Circulation, vol. 85, no. 6, pp. 2338–2344, 1992. View at Google Scholar · View at Scopus
  11. H. Gali-Muhtasib, A. Roessner, and R. Schneider-Stock, “Thymoquinone: a promising anti-cancer drug from natural sources,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 8, pp. 1249–1253, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Ragheb, A. Attia, W. S. Eldin, F. Elbarbry, S. Gazarin, and A. Shoker, “The protective effect of thymoquinone, an anti-oxidant and anti-inflammatory agent, against renal injury: a review,” Saudi Journal of Kidney Diseases and Transplantation, vol. 20, pp. 741–752, 2009. View at Google Scholar
  13. K. Prasad, J. Karla, and P. Lee, “Oxygen free radicals as a mechanism of hypercholesterolemic atherosclerosis: effects of probucol,” International Journal of Angiology, vol. 3, pp. 100–112, 1994. View at Google Scholar
  14. R. Kapoor and K. Prasad, “Role of oxyradicals in cardiovascular depression and cellular injury in hemorrhagic shock and reinfusion: effect of SOD and catalase,” Circulatory Shock, vol. 43, no. 2, pp. 79–94, 1994. View at Google Scholar · View at Scopus
  15. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Google Scholar · View at Scopus
  16. R. L. Holman, H. C. McGill Jr., J. P. Strong, and J. C. Geer, “Technics for studying atherosclerotic lesions,” Laboratory Investigation, vol. 7, pp. 42–47, 1958. View at Google Scholar
  17. Y. Wang, W. R. Burns, P. C. Tang et al., “Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries,” The FASEB Journal, vol. 18, no. 3, pp. 606–608, 2004. View at Google Scholar · View at Scopus
  18. H. Hosseinzadeh, S. Parvardeh, M. N. Asl, H. R. Sadeghnia, and T. Ziaee, “Effect of thymoquinone and Nigella sativa seeds oil on lipid peroxidation level during global cerebral ischemia-reperfusion injury in rat hippocampus,” Phytomedicine, vol. 14, no. 9, pp. 621–627, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Prasad, “Dietary flax seed in prevention of hypercholesterolemic atherosclerosis,” Atherosclerosis, vol. 132, no. 1, pp. 69–76, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Pakala, E. Stabile, G. J. Jang, L. Clavijo, and R. Waksman, “Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis,” Journal of Cardiovascular Pharmacology, vol. 46, no. 4, pp. 481–486, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Rezzani, “Exploring cyclosporine A-side effects and the protective role-played by antioxidants: the morphological and immunohistochemical studies,” Histology and Histopathology, vol. 21, no. 1–3, pp. 301–316, 2006. View at Google Scholar · View at Scopus
  22. Y.-J. Geng and G. K. Hansson, “Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages,” Journal of Clinical Investigation, vol. 89, no. 4, pp. 1322–1330, 1992. View at Google Scholar · View at Scopus
  23. A. M. Fogelman, J. Seager, M. E. Haberland, M. Hokom, R. Tanaka, and P. A. Edwards, “Lymphocyte-conditioned medium protects human monocyte-macrophages from cholesteryl ester accumulation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 79, pp. 922–926, 1982. View at Google Scholar
  24. A. C. Wilson, R. G. Schaub, R. C. Goldstein, and P. T. Kuo, “Suppression of aortic atherosclerosis in cholesterol-fed rabbits by purified rabbit interferon,” Arteriosclerosis, vol. 10, no. 2, pp. 208–214, 1990. View at Google Scholar · View at Scopus
  25. A. Martínez Castelao, R. Ramos, D. Serón et al., “Effect of cyclosporin and tacrolimus on lipoprotein oxidation after renal transplantation,” Nefrologia, vol. 22, no. 4, pp. 364–369, 2002. View at Google Scholar · View at Scopus
  26. R. Ross, “The pathogenesis of atherosclerosis: a perspective for the 1990s,” Nature, vol. 362, no. 6423, pp. 801–809, 1993. View at Publisher · View at Google Scholar · View at Scopus